These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Increasing number of companies found ineligible for SBIR funding. Bouchie A Nat Biotechnol; 2003 Oct; 21(10):1121-2. PubMed ID: 14520384 [No Abstract] [Full Text] [Related]
4. Chasing biotech, state by state--winners and losers. Wilan KH Nat Biotechnol; 2005 Feb; 23(2):175-9. PubMed ID: 15696143 [No Abstract] [Full Text] [Related]
8. Little science, big bucks. DeFrancesco L Nat Biotechnol; 2003 Oct; 21(10):1127-9. PubMed ID: 14520387 [No Abstract] [Full Text] [Related]
9. Biotechs get $1 billion windfall in R&D tax credits. Thiel K Nat Biotechnol; 2009 Dec; 27(12):1066. PubMed ID: 20010563 [No Abstract] [Full Text] [Related]
10. More than the sum of their parts? Clustering is becoming more prevalent in the biosciences, despite concerns over the sustainability and economic effectiveness of science parks and hubs. Rinaldi A EMBO Rep; 2006 Feb; 7(2):133-6. PubMed ID: 16452923 [TBL] [Abstract][Full Text] [Related]
11. Michigan's next wave of biopharmaceutical entrepreneurship. Kerppola R; van de Walle M; Surine S Nat Biotechnol; 2003 Sep; 21(9):1109-11. PubMed ID: 12949575 [No Abstract] [Full Text] [Related]